Bioxytran (OTC:BIXT) Stock, Quote.Headers.trade-ideas

Bioxytran Inc is a biopharmaceutical company. The company is engaged in developing anti-necrosis drugs that treat a variety of medical conditions resulting from Ischemia. It is also focusing on the development and commercialization of treatments to prevent catastrophic brain damage resulting from hypoxic conditions following brain stroke. Its product candidate, BXT-25, is an anti-necrosis drug that carries oxygen to tissues when the flow of blood is blocked.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ACSAF

ACSAY

AGTK

AJXGF

ALLO

APRN

ARCH

AREC

AVNS

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BRIDGEGATE PICTURES CORP by Bridgegate Pictures Corp.

BBGP

BIXT

BRDCY

CHFS

CONN

CTTAY

DESTQ

DFIHY

DLPH

DLTR

DRTT

DTGI

EDRY

EHOS

ELRA

FAMI

FDFT

FLURF

FREDQ

GEAHF

GLOG

GLOP

GPOR

GRST

GTCH

HBRM

HTBX

ICTPU

IHSI

INAR

IPSEY

JASN

KPLUY

KUKAY

KURA

LKCO

MDGL

MLHC

MOBQ

MYSZ

NHTC

NKRKY

PABN

PACD

PHBI

PLHNF

PETROTEQ ENERGY INC by Petroteq Energy Inc.

PQEFF

REMYY

RNET

RNLSY

RNSDF

SIAF

SNES

SPPI

TOIPF

TOMDF

TPAC

TRPX

UPWK

VQSLF

WETF

WISA

ICC INTL CANNABIS CORP by ICC Intl Cannabis Corp.

WLDCF

YAYO

ZOOMPASS HOLDINGS INC by Zoompass Holdings, Inc.

ZPAS

MCARY

Stocks That Hit 52-Week Lows On Friday

Bioxytran Inc

Press Releases

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

Bioxytran Announces Government Interest After Initial BARDA Techwatch Light Meeting

Bioxytran's Cancer Preprint Reveals Potential to Enhance Most Immunotherapy Drugs

Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now

Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Bioxytran Develops a Groundbreaking Treatment to Combat Bird Flu in Egg Laying Chickens Potentially Saving Billions

Bioxytran Signs NDA with the University of Georgia to Evaluate Galectin Antagonists for Bird Flu Treatment in Chickens

Comments

Bioxytran

Bioxytran (OTC:BIXT) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga